Novo Nordisk, generational buying opportunity? Novo Nordisk is currently experiencing one of the largest drawdowns in its history, primarily triggered by a downward revision of guidance for FY25 and FY26.
Focusing strictly on technical analysis:
For the first time, the monthly 200 EMA is serving as a key support level for Novo Nordisk -
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
14.18 PLN
57.83 B PLN
166.31 B PLN
3.16 B
About NOVO NORDISK B A/S
Sector
Industry
CEO
Maziar Mike Doustdar
Website
Headquarters
Bagsværd
Founded
1931
ISIN
DK0062498333
FIGI
BBG01VCLYS74
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Related stocks
NovoNordisk, LT dirt cheap | GLP-1 a misunderstood growth marketNovo Nordisk stock has lost quite some weight since the release of Eli lilly's drug Zepbound and Mounjaro and since the rise of compounded, or generic copycat GLP-1 alternatives. The growth of the company has slown down a bit, but the overall GLP-1 market growth is still impressive and misunderstood
NVO Weekly Chart AnalysisNovo Nordisk (NVO) recently saw a sharp drop with heavy volume, signaling strong selling pressure. The chart shows a potential recovery path if the stock holds support near $47.
🔄 Possible rebound levels:
First target: $58
Mid target: $71
Final target: $82
📊 Options flow shows strong call activ
NovoNordisk, possible rotation,safe green buy Zone after confirmNovo Nordisk got slammed after Patrick appeared in the Technical analysis and slammed the Price all the way down to goblintown. After some profit cuts and FUD in the market a possibly rotation is possible. The GLP-1 market is misunderstood. if a rotation is confirmed and some more facts will be shar
If you want to buy NOVO.....A follower asked for my opinion on this stock which he said many are shorting this and asks if he should be a contrarian instead.
I do not own this stock and has no intention to at this moment but just looking at the chart, here's my 2cents :
1) price has fallen by 70+% from the peak from June 202
Novo Nordisk (Revised) | NVO | Long at $47.78**This is a revised analysis from February 5, 2025: I am still in that position, but added significantly more below $50**
Novo Nordisk NYSE:NVO is now trading at valuations before its release of Wegovy and Ozempic... From a technical analysis perspective, it's within my "major crash" simple mov
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Curated watchlists where NVO is featured.
Frequently Asked Questions
The current price of NVO is 186.00 PLN — it has increased by 4.49% in the past 24 hours. Watch NVONORDSK stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange NVONORDSK stocks are traded under the ticker NVO.
NVO stock has risen by 3.06% compared to the previous week, the month change is a −26.92% fall, over the last year NVONORDSK has showed a −26.77% decrease.
We've gathered analysts' opinions on NVONORDSK future price: according to them, NVO price has a max estimate of 409.83 PLN and a min estimate of 170.76 PLN. Watch NVO chart and read a more detailed NVONORDSK stock forecast: see what analysts think of NVONORDSK and suggest that you do with its stocks.
NVO stock is 5.64% volatile and has beta coefficient of 1.51. Track NVONORDSK stock price on the chart and check out the list of the most volatile stocks — is NVONORDSK there?
Today NVONORDSK has the market capitalization of 816.64 B, it has decreased by −0.45% over the last week.
Yes, you can track NVONORDSK financials in yearly and quarterly reports right on TradingView.
NVONORDSK is going to release the next earnings report on Nov 5, 2025. Keep track of upcoming events with our Earnings Calendar.
NVO earnings for the last quarter are 3.39 PLN per share, whereas the estimation was 3.37 PLN resulting in a 0.46% surprise. The estimated earnings for the next quarter are 3.51 PLN per share. See more details about NVONORDSK earnings.
NVONORDSK revenue for the last quarter amounts to 43.69 B PLN, despite the estimated figure of 43.75 B PLN. In the next quarter, revenue is expected to reach 44.73 B PLN.
NVO net income for the last quarter is 15.07 B PLN, while the quarter before that showed 16.30 B PLN of net income which accounts for −7.57% change. Track more NVONORDSK financial stats to get the full picture.
NVONORDSK dividend yield was 1.83% in 2024, and payout ratio reached 50.28%. The year before the numbers were 1.35% and 50.35% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 10, 2025, the company has 76.3 K employees. See our rating of the largest employees — is NVONORDSK on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NVONORDSK EBITDA is 91.39 B PLN, and current EBITDA margin is 50.95%. See more stats in NVONORDSK financial statements.
Like other stocks, NVO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NVONORDSK stock right from TradingView charts — choose your broker and connect to your account.